Reata Pharmaceuticals, Inc. Operating Income 2016-2023 | RETA

Reata Pharmaceuticals, Inc. operating income from 2016 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Reata Pharmaceuticals, Inc. Annual Operating Income
(Millions of US $)
2022 $-278
2021 $-245
2020 $-226
2019 $-285
2018 $-77
2017 $-47
2016 $-7
2015 $-0
2014 $4
Reata Pharmaceuticals, Inc. Quarterly Operating Income
(Millions of US $)
2023-06-30 $-92
2023-03-31 $-110
2022-12-31 $-80
2022-09-30 $-70
2022-06-30 $-64
2022-03-31 $-64
2021-12-31 $-72
2021-09-30 $-58
2021-06-30 $-60
2021-03-31 $-55
2020-12-31 $-54
2020-09-30 $-54
2020-06-30 $-51
2020-03-31 $-67
2019-12-31 $-184
2019-09-30 $-39
2019-06-30 $-34
2019-03-31 $-29
2018-12-31 $-25
2018-09-30 $-30
2018-06-30 $-27
2018-03-31 $4
2017-12-31 $-17
2017-09-30 $-12
2017-06-30 $-11
2017-03-31 $-7
2016-12-31 $-4
2016-09-30 $-1
2016-06-30 $-1
2016-03-31 $-0
2015-12-31 $-1
2015-09-30 $0
2015-06-30 $-1
2015-03-31 $1